Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South Africa.
WHO recommends computer-aided detection (CAD) in chest X-ray (CXR) for systematic screening of TB. Increased detection of individuals with high CAD score but without bacteriologically confirmed TB can be expected, requiring guidance on their clinical management. We followed participants of a TB prev...
Saved in:
| Main Authors: | Maria Ruperez, Jacob Busang, Linda Mureithi, Kwame Shanaube, Eveline Klinkenberg, Thomas Gachie, James M Burnett, Barry Kosloff, Petra de Haas, Richard Hayes, Sarah Fidler, Ab Schaap, Sian Floyd, Helen Ayles, TREATS study team |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLOS Global Public Health |
| Online Access: | https://doi.org/10.1371/journal.pgph.0003787 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical outcomes of participants of a TB prevalence survey with an abnormal chest X-ray but no evidence of TB disease after a median follow-up of 9 months in Zambia and South Africa
by: Maria Ruperez, et al.
Published: (2025-01-01) -
Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
by: Eveline Klinkenberg, et al.
Published: (2023-09-01) -
Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa.
by: Kwame Shanaube, et al.
Published: (2009-11-01) -
Risk factors associated with positive QuantiFERON-TB Gold In-Tube and tuberculin skin tests results in Zambia and South Africa.
by: Kwame Shanaube, et al.
Published: (2011-04-01) -
Depressive symptoms and HIV risk behaviours among adolescents enrolled in the HPTN071 (PopART) trial in Zambia and South Africa.
by: Kwame Shanaube, et al.
Published: (2022-01-01)